FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.0  |  FHIR Version n/a  User: [n/a]

30141000087107: Vaccine product containing only severe acute respiratory syndrome coronavirus 2 virus-like particle antigen (medicinal product)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Oct 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
153021000087118 Vaccine product containing only Severe acute respiratory syndrome coronavirus 2 virus-like particle antigen (medicinal product) en Fully specified name Inactive Only initial character case insensitive (core metadata concept) Canada Health Infoway English module (core metadata concept)
153031000087116 Vaccine product containing only Severe acute respiratory syndrome coronavirus 2 virus-like particle antigen en Synonym (core metadata concept) Inactive Only initial character case insensitive (core metadata concept) Canada Health Infoway English module (core metadata concept)
153041000087110 COVID-19 virus-like particle unspecified en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) Canada Health Infoway English module (core metadata concept)
153051000087113 COVID-19 virus-like particle vaccine en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) Canada Health Infoway English module (core metadata concept)
162561000087115 COVID-19 vaccin à particules pseudo-virales non spécifié fr Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
4643542016 Vaccine product containing only Severe acute respiratory syndrome coronavirus 2 virus-like particle antigen (medicinal product) en Fully specified name Inactive Only initial character case insensitive (core metadata concept) SNOMED CT core
4643543014 COVID-19 virus-like particle antigen vaccine en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
4643544015 2019 novel coronavirus virus-like particle antigen vaccine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4643545019 Severe acute respiratory syndrome coronavirus 2 virus-like particle antigen only vaccine product en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4643546018 SARS-CoV-2 virus-like particle antigen vaccine en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
4669631015 Vaccine product containing only severe acute respiratory syndrome coronavirus 2 virus-like particle antigen (medicinal product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
COVID-19 virus-like particle unspecified est un(e) (attribut) SARS-CoV-2 antigen vaccine true Inferred relationship Some
COVID-19 virus-like particle unspecified Plays role Active immunity stimulant role (role) true Inferred relationship Some
COVID-19 virus-like particle unspecified a pour principe actif (attribut) antigène à particules pseudo-virales du SRAS-CoV-2 true Inferred relationship Some 1
COVID-19 virus-like particle unspecified a pour principe actif (attribut) antigène à particules pseudo-virales du SRAS-CoV-2 false Inferred relationship Some 1
COVID-19 virus-like particle unspecified Plays role Active immunity stimulant role (role) false Inferred relationship Some
COVID-19 virus-like particle unspecified est un(e) (attribut) SARS-CoV-2 antigen vaccine false Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Adverse reaction to COVID-19 virus-like particle antigen vaccine Causative agent True COVID-19 virus-like particle unspecified Inferred relationship Some 1
Administration of SARS-CoV-2 virus-like particle antigen vaccine substance utilisée (attribut) True COVID-19 virus-like particle unspecified Inferred relationship Some 1
Administration of second dose of SARS-CoV-2 virus-like particle antigen vaccine substance utilisée (attribut) True COVID-19 virus-like particle unspecified Inferred relationship Some 1
COVIFENZ virus-like particle 3.75 micrograms per 0.5 milliliter emulsion for injection Medicago Inc. (real clinical drug) est un(e) (attribut) True COVID-19 virus-like particle unspecified Inferred relationship Some

Reference Sets

Historical name codes for vaccines reference set (foundation metadata concept)

Back to Start